Here, the antimicrobial susceptibility, resistance mechanisms, and clonality of Mobiluncus sp. isolates recovered from gynecological outpatients in China were investigated. Compared to M. mulieris, M. curtisii exhibited higher antimicrobial resistance to metronidazole, clindamycin, and tetracycline. Whole-genome sequencing indicated that the clindamycin resistance gene erm(X) was located on a transposable element, Tn5432, which was composed of two IS1249 sequences.
KEYWORDS: Mobiluncus spp., antimicrobial resistance, clindamycin, metronidazole, whole-genome sequencing
ABSTRACT
Here, the antimicrobial susceptibility, resistance mechanisms, and clonality of Mobiluncus sp. isolates recovered from gynecological outpatients in China were investigated. Compared to M. mulieris, M. curtisii exhibited higher antimicrobial resistance to metronidazole, clindamycin, and tetracycline. Whole-genome sequencing indicated that the clindamycin resistance gene erm(X) was located on a transposable element, Tn5432, which was composed of two IS1249 sequences. Phylogenetic analysis indicated that Mobiluncus spp. had high diversity, with isolates being grouped into several sporadic clades.
INTRODUCTION
Mobiluncus spp. are obligate anaerobic, Gram-labile or Gram-negative curved bacilli of the vaginal flora that are highly correlated with bacterial vaginosis (1, 2). Analysis of the 16S rRNA gene sequences revealed that Mobiluncus spp. comprise two distantly related species, namely, Mobiluncus curtisii and Mobiluncus mulieris. Both species are associated with different types of conditions, such as vaginal abscesses, umbilical abscesses, endometritis, ulcerative colitis, and spontaneous preterm birth (3, 4). The treatment of Mobiluncus sp. infections is primarily based on empirical broad-spectrum antimicrobial therapy against anaerobes using metronidazole and clindamycin, which are frequently used first-line antianaerobic agents (5, 6). However, the increase in antimicrobial resistance of anaerobes over the recent decades is worrisome, since such resistance has been described in multidrug-resistant anaerobic bacteria (7). Because of their fastidious nature and strict nutritional requirements, these organisms are difficult to culture and isolate.
To date, there is only one study that has reported the prevalence and antimicrobial resistance rate in Mobiluncus isolates, which were recovered from Turkish women with gynecological infections from 1999 to 2002 (8). Data on the antimicrobial susceptibility and, more importantly, the resistance mechanisms and clonality of Mobiluncus isolates recovered from China are completely lacking. To address this point, the present study assessed the susceptibility of Mobiluncus isolates to penicillin, cefoxitin, imipenem, tetracycline, metronidazole, and clindamycin in China. The phylogenetic relationships among isolates and the mechanisms of resistance were also investigated.
In this study, all vaginal swabs were collected from gynecological outpatients between January 2017 and November 2018 at the Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, China. Two specimens of vaginal secretion were collected from each patient. One specimen was used for Gram staining to confirm the typical Mobiluncus sp. morphology under the microscope (i.e., curved bracket with two tapered ends), and the other specimen was used for culture-based separation. The vaginal discharge samples were inoculated onto Columbia blood agar plates (Oxoid, Basingstoke, United Kingdom) and placed under anaerobic conditions in anaerobic bags (bioMérieux, Marcy-l’Étoile, France) at 35°C for 3 to 5 days. Colonies were Gram stained to obtain organisms with the characteristic curved rod shape and subcultured to obtain pure cultures of each colony. A total of 63 Mobiluncus sp. isolates recovered from the vaginal discharge were identified using 16S rRNA gene sequencing. In all, 30 isolates (47.6%) were identified as M. curtisii, and 33 isolates (52.4%) were identified as M. mulieris (see Table S1 in the supplemental material). The antimicrobial susceptibility of Mobiluncus isolates against penicillin, cefoxitin, imipenem, tetracycline, clindamycin, and metronidazole was assessed using the Etest method. Briefly, Mobiluncus isolates were suspended in Brucella broth to obtain a density equivalent to the McFarland 1 standard and were further inoculated onto Brucella agar supplemented with 5% lysed sheep blood, 5 μg/ml hemin, and 1 μg/ml vitamin K1. The Etest strip was placed in the center of each 90-mm plate and incubated anaerobically at 35°C for 48 h (9, 10). The MICs of antibacterial agents were interpreted according to the breakpoints of anaerobes provided by the Clinical and Laboratory Standards Institute (CLSI) guidelines (11). Bacteroides fragilis strain ATCC 25285 was used for quality control. Ten M. curtisii isolates and eleven M. mulieris isolates were further selected for whole-genome sequencing using the Illumina NovaSeq platform. De novo genome assembly was performed using SPAdes 3.14. The macrolide resistance gene erm(X), tetracycline resistance gene tet(O)/tet(W), and lincomycin resistance gene Inu(C) were identified using the ResFinder 3.2 database. The reported mechanisms of antimicrobial resistance against metronidazole in other bacterial species were also searched, including the nitroimidazole reductase gene nim, the oxygen-insensitive NADPH nitroreductase gene rdxA, the NADPH flavin oxidoreductase gene frxA, and RND-family efflux pump genes. Genome-wide phylogenetic trees were constructed between the Mobiluncus isolates recovered in this study and previously sequenced strains retrieved from the NCBI GenBank database using a core genome single-nucleotide polymorphism (cgSNP) strategy. The phylogenetic relatedness of M. curtisii and M. mulieris strains was assessed using an online bacterial whole-genome sequence typing and source tracking database (BacWGSTdb) (12, 13). Easyfig was used to analyze the genetic surroundings of antimicrobial resistance genes and homologous regions between different isolates.
The results of antimicrobial susceptibility testing indicated that M. curtisii had a higher resistance rate than M. mulieris to (i) metronidazole (100% versus 63.6%), (ii) clindamycin (73.3% versus 54.5%), and (iii) tetracycline (30% versus 24.2%). None of the isolates had a reduced susceptibility to penicillin, cefoxitin, or imipenem. Detailed results of MIC distributions, MIC50 and MIC90 values, and the percentages of resistance of Mobiluncus isolates are shown in Table 1.
TABLE 1.
The MICs of six antimicrobial agents against 30 M. curtisii isolates and 33 M. mulieris isolates recovered from patients with bacterial vaginosis
| Antimicrobial agent | MICs (μg/ml) for:a |
|||||||
|---|---|---|---|---|---|---|---|---|
|
M. curtisii (n = 30) |
M. mulieris (n = 33) |
|||||||
| Range | 50% | 90% | R (%) | Range | 50% | 90% | R (%) | |
| Penicillin | 0.008–0.064 | 0.032 | 0.032 | 0 | <0.008–0.008 | <0.008 | 0.008 | 0 |
| Cefoxitin | 0.5–4 | 2 | 2 | 0 | <0.064–1 | 0.064 | 0.125 | 0 |
| Imipenem | 0.008–0.032 | 0.016 | 0.032 | 0 | <0.008–0.016 | 0.008 | 0.008 | 0 |
| Tetracycline | 0.064–16 | 4 | 8 | 30 | <0.064–16 | 4 | 8 | 24.2 |
| Clindamycin | <0.064–>256 | >256 | >256 | 73.3 | <0.064–>256 | >256 | >256 | 54.5 |
| Metronidazole | >32–>32 | >32 | >32 | 100 | 0.25–>32 | >32 | >32 | 63.6 |
R, resistance.
Among the 21 Mobiluncus isolates that were subjected to whole-genome sequencing, 16 isolates carried the macrolide resistance gene erm(X), 18 isolates carried the tetracycline resistance gene tet(O)/tet(W), 1 isolate carried the lincomycin resistance gene Inu(C), and 15 isolates carried both the erm(X) and tet(O)/tet(W) genes. Sixteen Mobiluncus sp. strains (eight M. curtisii strains and eight M. mulieris strains) carrying erm(X) exhibited a high level of resistance to clindamycin, with an MIC of >256 μg/ml, and five clindamycin-susceptible strains did not carry the erm(X) gene, which is consistent with the phenotypic data. The erm(X) gene was allocated to a specific region in the genome with a similarity of 100% to the composite transposable element Tn5432. Tn5432 comprises two IS1249 sequences, the erm(X) gene, and the transposase gene tnpCX, which may assist in the horizontal transfer of the erm(X) gene. Analysis of upstream and downstream sequences flanking Tn5432 revealed that the transposon was located between an ATP-binding protein and a hypothetical protein of unknown function. However, the erm(X) and tnpCX genes were missing in the clindamycin-susceptible isolates or carried only one copy of IS1249 in this region (Fig. 1). The tet(O) and tet(W) genes that encode ribosomal protection proteins were identified in 18 Mobiluncus sp. strains (8 M. curtisii strains and 10 M. mulieris strains). No specific transposon or insertion sequence was detected in the genetic surroundings of the tet(O)/tet(W) genes. The MICs of tetracyclines for the tet(O)/tet(W)-positive isolates were higher than those for the three tet(O)/tet(W)-negative isolates. Moreover, all the M. curtisii isolates and 63.6% of the M. mulieris isolates were resistant to metronidazole. Therefore, we screened all known metronidazole resistance genes from the whole-genome sequencing data, but none of the antimicrobial resistance determinants previously reported in other bacterial species were identified. However, we characterized an underlying gene that encodes an oxygen-insensitive NADPH nitroreductase, which has not been reported before. Multiple sequence alignments of the amino acid sequence of the nitroreductase among the M. mulieris isolates that are resistant and susceptible to metronidazole revealed two unique nonsynonymous mutations in the metronidazole-resistant isolates (R186Q and T192I), which can be responsible for the metronidazole resistance. In addition, almost all of the M. curtisii isolates shared the identical sequence of the nitroreductase gene (Fig. S1). The phylogenetic tree of Mobiluncus isolates had high diversity, with isolates being grouped into several clades, which indicated that these isolates are not epidemiologically related (they differed by >1,000 SNPs) (Fig. 2 and 3).
FIG 1.
Comparison of the homologous regions shared by clindamycin-resistant (I and II) and clindamycin-susceptible (III and IV) isolates. Arrows represent coding sequences [red arrows, erm(X); pink arrows, IS1249] and indicate the direction of transcription. The arrow size is proportional to the gene length.
FIG 2.
Recombination-filtered core genome phylogeny and the distribution of antimicrobial resistance genes for M. curtisii isolates. The cell in a different color indicates the presence of antimicrobial resistance genes, and the blank cell indicates the absence of the gene. Isolates sequenced in this study are in red.
FIG 3.

Recombination-filtered core genome phylogeny and the distribution of antimicrobial resistance genes for M. mulieris isolates. The cell in a different color indicates the presence of antimicrobial resistance genes, and the blank cell indicates the absence of the gene. Isolates sequenced in this study are in red.
Mobiluncus species are increasingly recognized as clinically significant anaerobic bacteria because of their potential pathogenicity linked to bacterial vaginosis and their ability to affect the normal vaginal flora (1, 14). An in vitro study indicated that Mobiluncus spp. significantly increased the proinflammatory cytokine production of vaginal epithelial cells, including the production of interleukin-1α (IL-1α), IL-1β, tumor necrosis factor-α (TNF-α), and IL-8 (15), and may promote the occurrence of bacterial vaginosis and accelerate its progression. The emergence of multidrug-resistant anaerobic bacterial strains that cause vaginosis, particularly those that are resistant to metronidazole and clindamycin, represents an increasing threat to public health (16–18). Oral or vaginal administration of metronidazole or clindamycin produced an initial response in 80% to 90% of patients, but 15% to 30% of these patients relapsed within 3 months due to the possible selection of potential antimicrobial-resistant strains (19). The limited therapeutic options available to combat infections caused by Mobiluncus spp. indicates the importance of studying the prevalence and mechanisms of resistance to first-line antimicrobial agents such as metronidazole and clindamycin.
Currently, limited data are available on the antimicrobial susceptibility of Mobiluncus spp., especially for individual species. One of the reasons for this limitation in data availability on Mobiluncus susceptibility relates to the known difficulty in cultivating these pathogens and in the performance of the agar dilution method. The antimicrobial resistance rate in Mobiluncus spp. varies widely among different countries and studies. The rates of resistance to clindamycin and metronidazole in our study were much higher than those in previously reported studies. For example, a Turkish study reported a metronidazole resistance rate of 24% in M. mulieris, while in a recent study conducted in the United States, a rate of 42% was reported (8, 20). The antimicrobial susceptibility rates of M. curtisii and M. mulieris to clindamycin were also higher than the rates reported by Bahar et al. (0% and 0%, respectively) and Petrina et al. (18% and 0%, respectively) (8, 20). The empirical overuse of first-line antibiotics in the community is a key driving force for the evolution of antimicrobial resistance in Mobiluncus spp. However, the possible inconsistencies in resistance rates between the aforementioned studies may also be due to the use of different methods/techniques for antimicrobial susceptibility testing (e.g., Etest and agar dilution).
Understanding the underlying mechanism of resistance is imperative. The erm(X) gene is only part of the nonconjugative composite transposon Tn5432, composed of two IS1249 elements, which is predominantly integrated into the chromosome (21). Whole-genome sequencing analysis of Mobiluncus spp. indicated that the horizontal transfer of the erm(X) gene via Tn5432 in Mobiluncus strains has resulted in an increased proportion of clindamycin-resistant Mobiluncus strains in China, which is consistent with the mechanism of resistance to macrolides in other bacterial species, e.g., Cutibacterium acnes and Bifidobacterium spp. (22, 23). In addition, the Mobiluncus strains carried a high proportion of tet(O)/tet(W) resistance genes, which encode ribosomal protection proteins that confer increased resistance to tetracycline. Our results indicated that the MIC of tetracycline was higher in tet(O)/tet(W)-carrying isolates than in noncarrying isolates, which is consistent with previous studies (24, 25). The mechanisms of metronidazole resistance in anaerobes are complex and multifactorial and have not been fully elucidated (26–28). The nim genes, which encode nitroimidazole reductase primarily in Bacteroides spp., are reported to be associated with metronidazole resistance (5, 29, 30). Mutations in the nitroreductase-encoding gene rdxA and oxidoreductase-encoding gene frxA in Helicobacter pylori can confer high-level resistance to metronidazole (5, 28). Other mechanisms, including overexpression of the RND-family efflux pump gene bme or the DNA repair effector recombinase A gene recA, are also involved in metronidazole resistance in Bacteroides fragilis (31, 32). In this study, we characterized several unique missense mutations in an underlying oxygen-insensitive NADPH nitroreductase gene in metronidazole-resistant Mobiluncus isolates by direct comparison of whole-genome sequencing data. These mutations identified in the nitroreductase-encoding gene can be associated with the low expression or inactivation of nitroreductases, which are needed to convert metronidazole to its active metabolites and resulting cytotoxicity, and can therefore mediate metronidazole resistance in Mobiluncus species. However, these preliminary findings warrant further investigation of the origin, transmission, and control of antimicrobial resistance using a large collection of samples.
In conclusion, our findings increase the knowledge of the antimicrobial susceptibility, resistance mechanisms, and clonality of multidrug-resistant Mobiluncus species in China. Continuous epidemiological surveillance is essential to monitor and prevent antimicrobial resistance from progressing to a clinically significant level.
Supplementary Material
ACKNOWLEDGMENTS
Y.Z. and Z.R. designed the study. Z.R. and X.Z. analyzed the data. Z.R., M.S.D., and X.Z. drafted the manuscript. Y.B. and L.Z. contributed to the isolation and phenotypic characterization of bacterial strains. All authors approved the final version of the manuscript.
We declare that there are no conflicts of interest.
This study was supported by the National Key R&D Program of China (2018YFC1002702).
Footnotes
Supplemental material is available online only.
REFERENCES
- 1.Zeng W, Ma H, Fan W, Yang Y, Zhang C, Arnaud Kombe Kombe J, Fan X, Zhang Y, Dong Z, Shen Z, Zhou Y, Yang M, Jin T. 2020. Structure determination of CAMP factor of Mobiluncus curtisii and insights into structural dynamics. Int J Biol Macromol 150:1027–1036. doi: 10.1016/j.ijbiomac.2019.10.107. [DOI] [PubMed] [Google Scholar]
- 2.Schwebke JR, Desmond RA. 2007. A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis. Clin Infect Dis 44:213–219. doi: 10.1086/509577. [DOI] [PubMed] [Google Scholar]
- 3.Elovitz MA, Gajer P, Riis V, Brown AG, Humphrys MS, Holm JB, Ravel J. 2019. Cervicovaginal microbiota and local immune response modulate the risk of spontaneous preterm delivery. Nat Commun 10:1305. doi: 10.1038/s41467-019-09285-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Dude CM, Saylany A, Brown A, Elovitz M, Anton L. 2020. Microbial supernatants from Mobiluncus mulieris, a bacteria strongly associated with spontaneous preterm birth, disrupts the cervical epithelial barrier through inflammatory and miRNA mediated mechanisms. Anaerobe 61:102127. doi: 10.1016/j.anaerobe.2019.102127. [DOI] [PubMed] [Google Scholar]
- 5.Alauzet C, Lozniewski A, Marchandin H. 2019. Metronidazole resistance and nim genes in anaerobes: a review. Anaerobe 55:40–53. doi: 10.1016/j.anaerobe.2018.10.004. [DOI] [PubMed] [Google Scholar]
- 6.Brook I, Wexler HM, Goldstein EJ. 2013. Antianaerobic antimicrobials: spectrum and susceptibility testing. Clin Microbiol Rev 26:526–546. doi: 10.1128/CMR.00086-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Schuetz AN. 2014. Antimicrobial resistance and susceptibility testing of anaerobic bacteria. Clin Infect Dis 59:698–705. doi: 10.1093/cid/ciu395. [DOI] [PubMed] [Google Scholar]
- 8.Bahar H, Torun MM, Ocer F, Kocazeybek B. 2005. Mobiluncus species in gynaecological and obstetric infections: antimicrobial resistance and prevalence in a Turkish population. Int J Antimicrob Agents 25:268–271. doi: 10.1016/j.ijantimicag.2004.09.019. [DOI] [PubMed] [Google Scholar]
- 9.Veloo AC, van Winkelhoff AJ. 2015. Antibiotic susceptibility profiles of anaerobic pathogens in The Netherlands. Anaerobe 31:19–24. doi: 10.1016/j.anaerobe.2014.08.011. [DOI] [PubMed] [Google Scholar]
- 10.Glupczynski Y, Berhin C, Nizet H. 2009. Antimicrobial susceptibility of anaerobic bacteria in Belgium as determined by E-test methodology. Eur J Clin Microbiol Infect Dis 28:261–267. doi: 10.1007/s10096-008-0624-1. [DOI] [PubMed] [Google Scholar]
- 11.Wayne P. 2012. Clinical and Laboratory Standards Institute methods for antimicrobial susceptibility testing of anaerobic bacteria, 8th ed Approved Standard, Document M11-A8 CLSI, Wayne, PA. [Google Scholar]
- 12.Ruan Z, Yu Y, Feng Y. 2020. The global dissemination of bacterial infections necessitates the study of reverse genomic epidemiology. Brief Bioinform 21:741–750. doi: 10.1093/bib/bbz010. [DOI] [PubMed] [Google Scholar]
- 13.Ruan Z, Feng Y. 2016. BacWGSTdb, a database for genotyping and source tracking bacterial pathogens. Nucleic Acids Res 44:D682–687. doi: 10.1093/nar/gkv1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Taylor-Robinson AW, Borriello SP, Taylor-Robinson D. 1993. Identification and preliminary characterization of a cytotoxin isolated from Mobiluncus spp. Int J Exp Pathol 74:357–366. [PMC free article] [PubMed] [Google Scholar]
- 15.Anahtar MN, Byrne EH, Doherty KE, Bowman BA, Yamamoto HS, Soumillon M, Padavattan N, Ismail N, Moodley A, Sabatini ME, Ghebremichael MS, Nusbaum C, Huttenhower C, Virgin HW, Ndung’u T, Dong KL, Walker BD, Fichorova RN, Kwon DS. 2015. Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity 42:965–976. doi: 10.1016/j.immuni.2015.04.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Workowski KA, Bolan GA, Centers for Disease Control and Prevention . 2015. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 64:1–137. [PMC free article] [PubMed] [Google Scholar]
- 17.Veloo ACM, Tokman HB, Jean-Pierre H, Dumont Y, Jeverica S, Lienhard R, Novak A, Rodloff A, Rotimi V, Wybo I, Nagy E, group Es . 2020. Antimicrobial susceptibility profiles of anaerobic bacteria, isolated from human clinical specimens, within different European and surrounding countries. A joint ESGAI study. Anaerobe 61:102111. doi: 10.1016/j.anaerobe.2019.102111. [DOI] [PubMed] [Google Scholar]
- 18.Boyanova L, Kolarov R, Mitov I. 2015. Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades. Anaerobe 31:4–10. doi: 10.1016/j.anaerobe.2014.05.004. [DOI] [PubMed] [Google Scholar]
- 19.Wilson J. 2004. Managing recurrent bacterial vaginosis. Sex Transm Infect 80:8–11. doi: 10.1136/sti.2002.002733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Petrina MAB, Cosentino LA, Rabe LK, Hillier SL. 2017. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. Anaerobe 47:115–119. doi: 10.1016/j.anaerobe.2017.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Hays C, Lienhard R, Auzou M, Barraud O, Guerin F, Ploy MC, Cattoir V. 2014. Erm(X)-mediated resistance to macrolides, lincosamides and streptogramins in Actinobaculum schaalii. J Antimicrob Chemother 69:2056–2060. doi: 10.1093/jac/dku099. [DOI] [PubMed] [Google Scholar]
- 22.Aoki S, Nakase K, Hayashi N, Noguchi N. 2019. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes. J Med Microbiol 68:26–30. doi: 10.1099/jmm.0.000875. [DOI] [PubMed] [Google Scholar]
- 23.Wang N, Hang X, Zhang M, Peng X, Yang H. 2017. New genetic environments of the macrolide-lincosamide-streptogramin resistance determinant erm(X) and their influence on potential horizontal transferability in bifidobacteria. Int J Antimicrob Agents 50:572–580. doi: 10.1016/j.ijantimicag.2017.04.007. [DOI] [PubMed] [Google Scholar]
- 24.Marotta F, Garofolo G, di Marcantonio L, Di Serafino G, Neri D, Romantini R, Sacchini L, Alessiani A, Di Donato G, Nuvoloni R, Janowicz A, Di Giannatale E. 2019. Antimicrobial resistance genotypes and phenotypes of Campylobacter jejuni isolated in Italy from humans, birds from wild and urban habitats, and poultry. PLoS One 14:e0223804. doi: 10.1371/journal.pone.0223804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Li Y, Chen X, Zhang Z, Wang L, Wang J, Zeng J, Yang J, Lu B. 2019. Microbiological and clinical characteristics of Streptococcus gallolyticus subsp. pasteurianus infection in China. BMC Infect Dis 19:791. doi: 10.1186/s12879-019-4413-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Dingsdag SA, Hunter N. 2018. Metronidazole: an update on metabolism, structure-cytotoxicity and resistance mechanisms. J Antimicrob Chemother 73:265–279. doi: 10.1093/jac/dkx351. [DOI] [PubMed] [Google Scholar]
- 27.Akhi MT, Ghotaslou R, Alizadeh N, Yekani M, Beheshtirouy S, Asgharzadeh M, Pirzadeh T, Memar MY. 2017. nim gene-independent metronidazole-resistant Bacteroides fragilis in surgical site infections. GMS Hyg Infect Control 12:Doc13. doi: 10.3205/dgkh000298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Lynch T, Chong P, Zhang J, Hizon R, Du T, Graham MR, Beniac DR, Booth TF, Kibsey P, Miller M, Gravel D, Mulvey MR, Canadian Nosocomial Infection Surveillance Program . 2013. Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolate. PLoS One 8:e53757. doi: 10.1371/journal.pone.0053757. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Veloo ACM, Chlebowicz M, Winter HLJ, Bathoorn D, Rossen J. 2018. Three metronidazole-resistant Prevotella bivia strains harbour a mobile element, encoding a novel nim gene, nimK, and an efflux small MDR transporter. J Antimicrob Chemother 73:2687–2690. doi: 10.1093/jac/dky236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ghotaslou R, Bannazadeh Baghi H, Alizadeh N, Yekani M, Arbabi S, Memar MY. 2018. Mechanisms of Bacteroides fragilis resistance to metronidazole. Infect Genet Evol 64:156–163. doi: 10.1016/j.meegid.2018.06.020. [DOI] [PubMed] [Google Scholar]
- 31.Steffens LS, Nicholson S, Paul LV, Nord CE, Patrick S, Abratt VR. 2010. Bacteroides fragilis RecA protein overexpression causes resistance to metronidazole. Res Microbiol 161:346–354. doi: 10.1016/j.resmic.2010.04.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Pumbwe L, Chang A, Smith RL, Wexler HM. 2007. BmeRABC5 is a multidrug efflux system that can confer metronidazole resistance in Bacteroides fragilis. Microb Drug Resist 13:96–101. doi: 10.1089/mdr.2007.719. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.


